EP Patent

EP2301544A1 — Quinoline derivatives as intermediates to mycobacterial inhibitors

Assigned to Janssen Pharmaceutica NV · Expires 2011-03-30 · 15y expired

What this patent protects

The present invention relates to novel substituted quinoline derivatives of formula (II-a) wherein the variables are as defined in the specification, as intermediates in the preparation of mycobacterial inhibitors.

USPTO Abstract

The present invention relates to novel substituted quinoline derivatives of formula (II-a) wherein the variables are as defined in the specification, as intermediates in the preparation of mycobacterial inhibitors.

Drugs covered by this patent

Patent Metadata

Patent number
EP2301544A1
Jurisdiction
EP
Classification
—
Expires
2011-03-30
Drug substance claim
No
Drug product claim
No
Assignee
Janssen Pharmaceutica NV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.